Exane Derivatives’s Allegion ALLE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$98 Hold
1
﹤0.01% 716
2022
Q1
$110 Hold
1
﹤0.01% 983
2021
Q4
$132 Hold
1
﹤0.01% 858
2021
Q3
$132 Hold
1
﹤0.01% 1020
2021
Q2
$134 Sell
1
-18
-95% -$2.46K ﹤0.01% 1025
2021
Q1
$2.39K Hold
19
﹤0.01% 665
2020
Q4
$2.21K Hold
19
﹤0.01% 618
2020
Q3
$1.88K Hold
19
﹤0.01% 566
2020
Q2
$1.94K Hold
19
﹤0.01% 506
2020
Q1
$1.75K Hold
19
﹤0.01% 508
2019
Q4
$2.38K Hold
19
﹤0.01% 484
2019
Q3
$1.97K Hold
19
﹤0.01% 490
2019
Q2
$2.1K Hold
19
﹤0.01% 505
2019
Q1
$1.72K Buy
+19
New +$1.65K ﹤0.01% 462

Other funds holding ALLE

Exane Derivatives's ALLE Position: Q2 2022 in Review

Exane Derivatives held its Allegion (ALLE) position steady in Q2 2022 at 1 share worth $98. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Exane Derivatives first reported a position in ALLE in Q1 2019 and has held it in 14 quarters since. The position peaked at $2.39K in Q1 2021. 511 funds tracked by Wall St. Rank hold ALLE as of Q2 2022.

  • Exane Derivatives held 1 share of Allegion worth $98 as of Q2 2022.
  • Exane Derivatives left its Allegion share count unchanged in Q2 2022.
  • Allegion made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #716 holding.
  • Exane Derivatives first reported a position in Allegion in Q1 2019 and has held it in 14 quarters since.
  • Exane Derivatives's Allegion position peaked at $2.39K in Q1 2021.
  • 511 funds tracked by Wall St. Rank held Allegion as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.